[{"data":1,"prerenderedAt":164},["ShallowReactive",2],{"drug-teriparatide":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":22,"regimens":36,"contraindications":61,"warnings":71,"renal":72,"monitoring":73,"interactions":74,"review":75,"examples":78,"atc":85,"iran":87,"links":103,"populations":124,"usApproval":159},"teriparatide",1,{"fa":7,"en":8},"تری‌پاراتاید","Teriparatide","systemic-hormones",{"fa":11,"en":12},"آنالوگ هورمون پاراتیروئید (آنابولیک استخوان)","Parathyroid hormone analogue (bone anabolic)",[14],{"name":15,"market":16},"Forteo","US",[18,19,20,21],"forteo","فورتئو","تری پاراتاید","سینوریتید",[23],{"id":24,"form":25,"route":26,"label":27,"concentration":28,"markets":31,"refs":32},"pen","injection","sc","Pen 250 mcg\u002FmL (20 mcg per dose)",{"amount":29,"unit":30,"perVolumeMl":5},250,"mcg",[16],[33],{"source":34,"section":35},"fda-forteo","3",[37],{"id":38,"disease":39,"label":40,"population":43,"type":47,"unit":30,"dose":48,"refs":50,"notes":53},"op","osteoporosis",{"fa":41,"en":42},"پوکی استخوان پرخطر — ۲۰ mcg زیرجلدی یک بار در روز","High-risk osteoporosis — 20 mcg SC once daily",{"minAge":44},{"value":45,"unit":46},18,"year","fixed",{"perDose":49,"dosesPerDay":5},20,[51],{"source":34,"section":52},"2.1",[54],{"text":55,"refs":58},{"fa":56,"en":57},"در ران یا شکم. دوز اول در وضعیت نشسته یا درازکش (افت فشار وضعیتی).","Into the thigh or abdomen. Give the first doses sitting or lying down (orthostatic hypotension).",[59],{"source":34,"section":60},"2.2",[62],{"id":63,"severity":64,"text":65,"refs":68},"hyper","block",{"fa":66,"en":67},"حساسیت به تری‌پاراتاید یا اجزای فرآورده.","Hypersensitivity to teriparatide or its excipients.",[69],{"source":34,"section":70},"4",[],[],[],[],{"status":76,"reviewer":77,"date":77},"unverified",null,[79],{"regimen":38,"formulation":24,"input":80,"expect":83},{"ageYears":81,"weightKg":82},70,60,{"perDose":49,"mlPerDose":84},0.08,[86],"H05AA02",{"status":88,"forms":89,"refs":98},"registered",[90,94],{"code":91,"en":92,"fa":93},"11464","TERIPARATIDE 250MCG\u002FML 2.4ML INJ","فرآورده تزریقی تریپاراتاید ۲۵۰ میکروگرم \u002F میلی‌لیتر ۲٫۴ میلی‌لیتر",{"code":95,"en":96,"fa":97},"06027","TERIPARATIDE 750MCG\u002F3ML VIAL","ویال تریپاراتاید ۷۵۰ میکروگرم \u002F ۳ میلی‌لیتر",[99],{"source":100,"section":101,"url":102},"darooyab-generic","G-1446\u002FTeriparatide","https:\u002F\u002Fwww.darooyab.ir\u002FG-1446\u002FTeriparatide",[104,108,112,116,119,122],{"kind":105,"url":106,"label":107},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=021318","NDA021318",{"kind":109,"url":110,"label":111},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=aae667c5-381f-4f92-93df-2ed6158d07b0","FDA Forteo",{"kind":113,"url":114,"label":115},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa624051.html","Palopegteriparatide Injection",{"kind":113,"url":117,"label":118},"https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa603018.html","Teriparatide Injection",{"kind":120,"url":121,"label":86},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=H05AA02",{"kind":123,"url":102,"label":8},"darooyab",{"pregnancy":125,"lactation":134,"pediatric":142,"geriatric":150},{"level":126,"text":127,"quote":130,"refs":131},"caution",{"fa":128,"en":129},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary There are no available data on FORTEO use in pregnant women to evaluate for drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.",[132],{"source":34,"section":133},"8.1",{"level":126,"text":135,"quote":138,"refs":139},{"fa":136,"en":137},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Avoid FORTEO use in women who are breastfeeding.",[140],{"source":34,"section":141},"8.2",{"level":126,"text":143,"quote":146,"refs":147},{"fa":144,"en":145},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","The safety and effectiveness of FORTEO have not been established in pediatric patients.",[148],{"source":34,"section":149},"8.4",{"level":151,"text":152,"quote":155,"refs":156},"ok",{"fa":153,"en":154},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No overall differences in safety or effectiveness of FORTEO have been observed between patients 65 years of age and older and younger adult patients.",[157],{"source":34,"section":158},"8.5",{"kind":160,"refs":161,"id":107},"NDA",[162],{"source":34,"section":163},"SPL approval \u002F marketing category",1792115197045]